MoPH Qatar calls on pregnant women, seniors, and people with chronic illness to receive the RSV vaccine now available across HMC hospitals and health centres.
MoPH Qatar Urges High-Risk Groups to Get RSV Vaccine as Protection Efforts Expand
Doha: The Ministry of Public Health Qatar has called on vulnerable members of the community to receive the MoPH Qatar RSV vaccine, which is now available at HMC hospitals and primary health care centres across the country.
The ministry said the step reflects its continued commitment to protecting public health, limiting the spread of infectious diseases, and keeping national prevention policies aligned with the latest medical research.
Vaccine Part of Ongoing Public Health Strategy
Officials said the RSV vaccine Qatar campaign forms part of wider efforts to strengthen health regulations, refresh preventive guidelines, and add newly approved vaccines to the national immunisation program.
Health authorities confirmed the vaccine has received approval from international health organisations due to its strong ability to protect against the virus and its complications, especially among people most at risk.
The vaccine has also shown a high safety profile, with limited side effects. It has now been included as a recommended vaccine in Qatar’s national schedule, as well as in many countries worldwide.
Who Is Most at Risk?
The Ministry of Public Health Qatar outlined the groups strongly advised to receive the vaccine.
These include pregnant women between 28 and 36 weeks, helping protect both mothers and newborns. Other high-risk groups include people aged 60 and above, adults between 18 and 59 with chronic illnesses such as heart disease, lung conditions, diabetes, or kidney disorders, and individuals with weakened immune systems due to medical conditions or long-term treatments.
The ministry urged all eligible groups, especially expectant mothers, to get vaccinated as soon as possible. Officials noted the vaccine offers strong protection that can last up to two years.
Understanding Respiratory Syncytial Virus
Respiratory Syncytial Virus Qatar cases often begin with symptoms similar to the common cold. For many people, it passes without serious trouble. Yet for infants, older adults, pregnant women, and those living with chronic disease, RSV can cause severe lower respiratory infections and dangerous complications.
Health experts warn that RSV remains one of the leading viral causes of hospital admissions among young children and seniors worldwide.
Global Impact Raises Urgency
According to global health data, RSV is linked to more than 100,000 deaths each year and around 3.6 million hospitalisations.
Officials said these figures highlight why RSV prevention Qatar efforts remain a public health priority.
With the MoPH Qatar RSV vaccine now widely available, health leaders say early protection can ease pressure on hospitals, reduce severe illness, and help families feel safer during respiratory virus seasons.
